Research and Markets has announced the addition of the "IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Belgium" report to their offering.
The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of the IMS pricing and reimbursement specialists to provide industry players and decision makers with a thorough understanding of the rules and regulations governing P&R in international markets.
This report covers key developments in P&R, market access, cost containment, trade margins and healthcare issues.
Key Topics Covered:
1. HEALTHCARE SYSTEM
Facts & Figures
Provision & Funding
Statutory Health Insurance
Private Health Insurance
Regulation & Provision
Reimbursed Prescription Drugs
Non-reimbursed Prescription Drugs
Admission to Reimbursement
Standard Reimbursement Procedure
Expedited Reimbursement Procedure
Fast-track Procedure: Unmet Clinical Need
Managed Entry Agreements
Reference Price Reimbursement System
Maximum Reimbursement Prices
Changes in Reimbursement Status
Class 1 Drugs
5. PRICE BUILD-UP
6. COST CONTAINMENT
Orphan Drugs Tax
Per Pack Tax
Code of Conduct
7. FUTURE DEVELOPMENTS
Cost containment Measures
Hospital Sector Reforms
8. NAMES & ADDRESSES
For more information about this report visit http://www.researchandmarkets.com/research/xmdkt4/ims
View source version on businesswire.com: http://www.businesswire.com/news/home/20161004005685/en/Business Wire
Last updated on: 04/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.